Since primary cell line cells did not exhibit the effectof JNK inhibition on cell viability at low cisplatin concentrationfound in A549 cells, we can presume that the cisplatin concentration-dependentchange in the role of JNK is not specific to lung cancer cells; itrather depends on the oncogenic mutation. This evidence concerns the gene MAPK8 and lung cancer.